Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Return on Assets (2016 - 2022)

Edesa Biotech's Return on Assets history spans 9 years, with the latest figure at 1.01% for Q2 2022.

  • For Q2 2022, Return on Assets fell 33.0% year-over-year to 1.01%; the TTM value through Jun 2022 reached 1.01%, down 33.0%, while the annual FY2021 figure was 1.05%, 49.0% down from the prior year.
  • Return on Assets for Q2 2022 was 1.01% at Edesa Biotech, up from 1.11% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.41% in Q2 2019 and bottomed at 1.18% in Q4 2021.
  • The 5-year median for Return on Assets is 0.68% (2020), against an average of 0.73%.
  • The largest annual shift saw Return on Assets surged 36bps in 2019 before it crashed -48bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.53% in 2018, then dropped by -1bps to 0.53% in 2019, then crashed by -79bps to 0.96% in 2020, then fell by -23bps to 1.18% in 2021, then rose by 14bps to 1.01% in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Return on Assets are 1.01% (Q2 2022), 1.11% (Q1 2022), and 1.18% (Q4 2021).